Key Word(s): 1. chronic hepatitis; 2. hepatocellular carcinoma; 3. awareness Presenting Author: JEE EUN YANG Additional Authors: DANBI LEE, JU HYUN SHIM, KANG MO KIM, YOUNG SUK LIM, Erlotinib manufacturer HAN CHU LEE, YOUNG HWA CHUNG, YUNG SANG LEE Corresponding Author: JEE EUN YANG Affiliations: Asan Medical Center, Asan Medical Center, Asan Medical Center, Asan Medical Center, Asan

Medical Center, Asan Medical Center, Asan Medical Center Objective: Congenital hepatic fibrosis (CHF) is rare disorder with variable degree of periportal fibrosis and irregular proliferating bile ducts. Most patients are diagnosed in their infancy or childhood, however presentations as late as in the fifth decade have been reported. Our study describes clinical manifestation and outcome of late onset CHF patients. Methods: We retrospectively analyzed data of patients diagnosed as CHF

in adulthood at Asan Medical Center between January 1990 and December 2013. this website With liver biopsy or compatible CT images, 21 patients were diagnosed as latent onset CHF. Results: The median age of presentation was 30.0 years (range 19-58 years). 18 patients were male and 3 patients were female. The most frequent symptom was fever related to recurrent cholangitis or biliary sepsis. (6 patients, 28.6%) 5 patients presented with esophageal varix bleeding. Median total bilirubin was 1.15 mg/dL (range 0.93-2.07) and median PT (INR) was also in normal range. (1.2 INR (range 0.2-4.3) 7 patients had small or large renal cysts, however only Ceramide glucosyltransferase one of them developed terminal renal insufficiency. Of our 21 patients, only 3 patients had liver transplantation. Except 6 patients with loss of follow up, all patients are alive and well after individualized treatment including esophageal variceal ligation or endoscopic retrograde cholangiopancreatography. Conclusion: Latent onset type of CHF is likely to develop less severe phenotype and significant comorbidity

than neonatal or childhood onset CHF. Key Word(s): 1. congenital hepatic fibrosis Presenting Author: SOO HYUN YANG Additional Authors: WON HYEOK PARK, TAE GYOON KIM, SEO YOUNG YANG, WOONG SUN YOO, DO YOUNG KIM Corresponding Author: YOUNG KIM DO Affiliations: Veterans Health Service Medical Center, Veterans Health Service Medical Center, Veterans Health Service Medical Center, Veterans Health Service Medical Center, Veterans Health Service Medical Center Objective: Bacterial infections are life-threatening complications in patients with cirrhosis. But it is rather difficult who patients with hepatocellular carcinoma after transarterial chemoembolization. The goal of this study was to determine the ability of serum procalcitonin in the diagnosis of bacterial infection in cirrhosis patients with hepatocellular carcinoma after chemoembolization.